|
Volumn 24, Issue 13, 1997, Pages 1902-1909
|
Head and neck cancer
a a a |
Author keywords
Head and neck cancer; Nedaplatin; S l; Taxol; Taxotere
|
Indexed keywords
5 CHLORO 2,4 DIHYDROXYPYRIDINE;
5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR;
AMONAFIDE;
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
FLUOROURACIL;
GRANULOCYTE COLONY STIMULATING FACTOR;
HYDROXYUREA;
NAVELBINE;
NEDAPLATIN;
NOLATREXED;
OXONIC ACID;
PACLITAXEL;
PYRIDINE DERIVATIVE;
TEGAFUR;
TOPOTECAN;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MIXTURE;
HEAD AND NECK CANCER;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
PHASE 2 CLINICAL TRIAL;
SQUAMOUS CELL CARCINOMA;
STOMATITIS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
CLINICAL TRIALS, PHASE II;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HUMANS;
ORGANOPLATINUM COMPOUNDS;
PACLITAXEL;
TAXOIDS;
|
EID: 0030810238
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (18)
|